Karyopharm Therapeutics reported $-140280000 in Equity Capital and Reserves for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Equity Capital And Reserves Change
Amgen AMGN:US USD 3.65B 1.23B
AstraZeneca AZN:LN USD 35.13B 798M
Astrazeneca AZN:US USD 35.13B 798M
Avrobio Inc AVRO:US USD 98.09M 20.25M
Biocryst Pharmaceuticals BCRX:US USD -242659000 29.43M
Bristol Myers Squibb BMY:US USD 32.67B 71M
Eli Lilly And LLY:US USD 10.07B 1.53B
Enanta Pharmaceuticals ENTA:US USD 321.33M 16.69M
GlaxoSmithKline GSK:LN GBP 9.15B 7.22B
Karyopharm Therapeutics KPTI:US USD -140280000 23.94M
Macrogenics MGNX:US USD 122.96M 19.52M
Mirati Therapeutics MRTX:US USD 1.13B 17.05M
Nektar Therapeutics NKTR:US USD 412.22M 46.51M
Novartis NVS:US USD 60.82B 2.1B
Novartis NOVN:VX USD 60.82B 2.1B
Regeneron Pharmaceuticals REGN:US USD 21.44B 751M
Roche Holding ROG:VX 25.19B 700M
Sangamo Biosciences SGMO:US USD 309.15M 9.13M
Takeda 4502:JP JPY 6.71T 396.1B
Tg Therapeutics TGTX:US USD 100.48M 28.55M
Ultragenyx Pharmaceutical RARE:US USD 468.83M 209.24M
Xencor XNCR:US USD 722.7M 19.64M
YTE INCY:US USD 4.23B 141.59M